Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma
Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin
II Infused Mice
Figure 1
Mean arterial pressure of PPAR-α KO mice [18] (•) and PPAR-α WT mice [9] (o) during control days 1–13 and treatment of Ang II days 1–12. MAP was significantly higher in Ang II-treated PPAR-α KO versus Ang II-treated WT mice (*).
